Genetic Alterations

  • M. Perucho
  • J. Schaeffer
  • A. Velazquez
  • G. Berrozpe
  • G. Capella
Conference paper


Pancreatic carcinoma is nearly always fatal, with a 5-year survival rate of 3%–5%. Although cigarette smoking is considered to be a risk factor, the etiology of this cancer is essentially unknown. The hypothesis that accumulative genetic alterations underlie the multistage process of tumorigenesis is becoming increasingly accepted. Mutations activate the malignant potential of oncogenes and inactivate the repressor function of tumor suppressor genes (reviewed in Bishop 1991). The paradigmatic examples of these genes are the ras oncogenes and the P53 tumor suppressor gene.


Pancreatic Cancer Pancreatic Carcinoma Lynch Syndrome Hereditary Nonpolyposis Colorectal Cancer Mutator Mutation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aaltonen LA et al. (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260:812–816PubMedCrossRefGoogle Scholar
  2. Almoguera C, Shibata D, Forrester K, Martin J, Perucho M (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549–554PubMedCrossRefGoogle Scholar
  3. Ames BN, Gold LS (1990) Too many rodent carcinogens: mitogenesis increase mutagenesis. Since 249:970–971CrossRefGoogle Scholar
  4. Balmain A, Brown K (1988) Oncogene activation in chemical carcinogenesis. Adv Cancer Res 51:147–182PubMedCrossRefGoogle Scholar
  5. Baker SJ, Markowitz S, Fearon EJ, Willson JKV, Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wild-type P53. Science 249:912–915PubMedCrossRefGoogle Scholar
  6. Barbacid M (1987) ras genes. Annu Rev Biochem 56:779 – 827PubMedCrossRefGoogle Scholar
  7. Bishop JM (1991) Molecular themes in oncogenesis. Cell 64:235–248PubMedCrossRefGoogle Scholar
  8. Boguski MS, McCormick F (1993) Proteins regulatingRas and its relatives. Nature 366:643 – 654PubMedCrossRefGoogle Scholar
  9. Bos JL (1989) ras Oncogenes in human cancer: a review. Cancer Res. 49:4682–4689PubMedGoogle Scholar
  10. Cairns J (1975) Mutation selection and the natural history of cancer. Nature 255:197–200PubMedCrossRefGoogle Scholar
  11. Capella G, Cronauer-Mitra S, Peinado MA, Perucho M (1991) Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ Health Perspect 93:125–131PubMedCrossRefGoogle Scholar
  12. Chen PL, Chen Y, Bookstein R, Lee WH (1990) Genetic mechanisms of tumor suppression by the human P53 gene. Science 250:1576 –1580PubMedCrossRefGoogle Scholar
  13. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027–1038PubMedCrossRefGoogle Scholar
  14. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M (1987) Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327:298–303PubMedCrossRefGoogle Scholar
  15. Fujii H, Egami H, Chaney W, Pour P, Pelling J (1990) Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Mol Carcinog 3:296 – 301PubMedCrossRefGoogle Scholar
  16. Gonzalez-Zulueta M, Ruppert JM, Tokino K, Tsai Y, Spruck CH, Miyao N, Nichols PW, Herman GG, Horn T, Steven K, Summerhayes IC, Sidranski D, Jones P (1993) Microsatellite instability in bladder cancer. Cancer Res 53:5620 – 5623PubMedGoogle Scholar
  17. Han H-J, Yanasigawa A, Kato Y, Park J-G, Nakamura Y (1993) Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 53:5087–5089PubMedGoogle Scholar
  18. Harris CC (1991) Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res 51:5023S–5044SPubMedGoogle Scholar
  19. Hollstein M, Sidransky D, Vogelstein B, Harris C (1991) p53 mutations in human cancers. Science 253:49–53PubMedCrossRefGoogle Scholar
  20. Hoorens A, Lemoine NR, McLelland E, Morohoshi T, Kamisawa T, Heitz PU, Stamm B, Ruschoff J, Wiedenmann B, Kloppel G (1993) Pancreatic acinar carcinoma. An analyis of cell lineage markers, p53 expression and Ki-ras mutation. Am J Pathol 143:685 – 698PubMedGoogle Scholar
  21. Hruban RH, van Mansfeld ADM, Offerhaus GJ, van Weering DHJ, Allison D, Goodman SN, Kensler TW, Bose KK, CameronJL, Bos JL (1993). K-ras oncogene activation in adeno-carcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allelespecific oligonucleotide hybridization. Am J Pathol 143:545–554PubMedGoogle Scholar
  22. Hunter T (1991) Cooperation between oncogenes. Cell 64:249–270PubMedCrossRefGoogle Scholar
  23. Ionov J, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558–561PubMedCrossRefGoogle Scholar
  24. Lasko D, Cavenee W, Nordenskjold M (1991) Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 25:281 – 314PubMedCrossRefGoogle Scholar
  25. Leach FS et al. (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215 –1225PubMedCrossRefGoogle Scholar
  26. Lindblom A, Tannergard P, Werelius B, Nordenskjold M (1993) Genetic mapping of a second locus predisposing to hereditarty non-polyposis colon cancer. Nature Genet 5:279 – 282PubMedCrossRefGoogle Scholar
  27. Lipkin M, Newmark H (1985) Effect of added dietary calcium on colonic epithelial cell proliferation in subjects at high risk for familial colon cancer. N Engl J Med 313:1381–1384PubMedCrossRefGoogle Scholar
  28. Loeb LA, Springgate CF, Battula N (1974) Errors in DNA replication as a basis of malignant changes. Cancer Res 34:2311– 2321PubMedGoogle Scholar
  29. Love RR (1985) Small bowel cancers, B-cell lymphatic leukemia, and six primary cancers with metastases and prolonged survival in the cancer family syndrome of Lynch. Cancer Res 55:499–502Google Scholar
  30. Lynch HT, Lynch PM, Pester J, Fusaro RM (1981) The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre’s syndrome. Arch Intern Med 141:607–611PubMedCrossRefGoogle Scholar
  31. Lynch HT, Voorhees GJ, Lanspa SJ, McGreevy PS, Lynch JF (1985) Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br J Cancer 52:271–273PubMedCrossRefGoogle Scholar
  32. Lynch HT, Lanspa S, Smyrk T, Boman B, Watson P, Lynch J (1991) Hereditary nonpolyposis colorectal cancer (Lynch syndrome I and II). Cancer Genet Cytogenet 143:160–170Google Scholar
  33. Mariyama M, Kishi K, Nakamura K, Obata H, Nishimura S (1989) Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. Jpn J Cancer Res 80:622–626PubMedCrossRefGoogle Scholar
  34. Marx J (1993) How p53 suppresses cell growth. Sience 262:1644–1645CrossRefGoogle Scholar
  35. McCormick F (1989) ras GTPase activating protein: signal transmitter and signal terminator. Cell 56:5–8PubMedCrossRefGoogle Scholar
  36. Mecklin J-P, Jarvinen HJ (1986) Clinical features of colorectal carcinoma in cancer family syndrome. Dis Colon Rectum 29:160–164PubMedCrossRefGoogle Scholar
  37. Mullis KB, Faloona FA (1987) Specific synthesis of DNA in vitro via a polymerase catalyzed chain reaction. Methods Enzymol 155:335–350PubMedCrossRefGoogle Scholar
  38. Nagata Y, Abe M, Motoshima K, Nakayama E, Shiku H (1990) Frequent glycine-to-aspartic acid mutations at codon 12 of c-K-ras gene in human pancreatic carcinomas. Jpn J Cancer Res 81:135–140PubMedCrossRefGoogle Scholar
  39. Nelson RL, Mason HS (1972) An explicit hypothesis for chemical carcinogenesis. J Theor Biol 37:197–200PubMedCrossRefGoogle Scholar
  40. Okamoto M, Ohtsu H, Miyaki M, Yonekawa H (1993) No allelic loss at the p53 locus in 1,2-dimethylhydrazine-induced mouse colon tumors: PCR-SSCP analysis with sequence-tagged microsatellite site primers. Carcinogenesis 14:1483–1486PubMedCrossRefGoogle Scholar
  41. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-stranded conformation polymporphisms. Proc Natl Acad Sci USA 86:2766 – 2770PubMedCrossRefGoogle Scholar
  42. Peinado MA, Malkhosyan S, Velazquez A, Perucho M (1992) Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase cahin reaction. Proc Natl Acad Sci USA 89:10065–10069PubMedCrossRefGoogle Scholar
  43. Peinado MA, Fernandez-Renart M, Capella G, Wilson L, Perucho M (1993) Mutations in the p53 suppressor gene do not correlate with c-K-ras oncogene mutations in colorectal cancer. Int J Oncol 2:123–134PubMedGoogle Scholar
  44. Peltomaki P et al. (1993) Genetic mapping of a locus predisposing to human colorectal cancer. Science 260:810–812PubMedCrossRefGoogle Scholar
  45. Perucho M, Forrester K, Almoguera C, Kahn S, Lama C, Shibata D, Arnheim N, Grizzle WE (1989) Expression and mutational activation of the c-Ki-ras gene in human carcinomas. Cancer Cells 7 (Mol Diagn Hum Cancer) 137–141Google Scholar
  46. Potten CS, Loeffler M (1987) A comprehensive model of the crypts of the small intestine of the mouse provides insight into the mechanisms of cell migration and the proliferation hierarchy. J Theor Biol 127:381–391PubMedCrossRefGoogle Scholar
  47. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J (1993) Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 53:5100–5103PubMedGoogle Scholar
  48. Schaeffer BK, Zurlo J, Longnecker DS (1990) Activation of c-Ki-ras not detectable in adenomas or adenocarcinomas arising in rat pancreas. Mol Carcinog 3:165–170PubMedCrossRefGoogle Scholar
  49. Shibata D, Almoguera C, Forrester K, Dunitz J, Martin SE, Cosgrove M, Perucho M, Arnheim N (1990a). Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas. Cancer Res 50:1279–1283PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • M. Perucho
  • J. Schaeffer
  • A. Velazquez
  • G. Berrozpe
  • G. Capella

There are no affiliations available

Personalised recommendations